Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00076271 · ClinicalTrials.gov registry record
Evaluation and Treatment of Pediatric, Developmental, and Genetic Eye Diseases
A clinical trial of Eye Diseases, sponsored by National Eye Institute (NEI).
- Completed
- Registry status
- 350
- Enrollment target
- 2
- Study locations
NCT00076271 is a study of Eye Diseases that has completed, run by National Eye Institute (NEI). The registered enrollment target is 350 participants, below the 741,290-participant average among 27 other Eye Diseases trials with a reported enrollment target (100% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT00076271, a study of Eye Diseases, has completed, sponsored by National Eye Institute (NEI).
- COMPLETED
- Registry status
- 350 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study will evaluate and treat children or adults with inherited or developmental eye conditions. It will allow specialists in pediatric ophthalmology, genetic ophthalmology, and ocular motility at the National Eye Institute (NEI) to learn more about the course of various pediatric, genetic, developmental, and eye movement diseases thorough long-term observation and treatment. It will also serve as the first step in determining the eligibility of patients who may wish to enroll in other NEI clinical research studies or undergo standard eye treatments. Children with eye conditions, especially inherited or developmental conditions, and adults with eye disorders that began in childhood or that likely have a genetic or developmental component may be eligible for this study. Participants will undergo some or all of the following procedures: * Medical history, including family history. * Physical examination and possibly routine blood tests, x-rays tests, standard eye movement recordings, questionnaires, and specialized procedures when needed. * Complete eye examination, including vision test, visual perception, eye pressure (if possible), dilation of the pupils to examine the back of the eye (lens, vitreous, and retina). * Photographs of the eyes. * Oculography (eye movement recordings) in patients for whom testing will aid in diagnosis. This test is done either with goggles placed over the eyes or with a contact lens placed on each eye. When the goggles or lenses are in place, the subject looks at a series of red targets on a computer screen. * Electroretinography (ERG) in patients with suspected retinal degeneration. This is a test of the electrical function of the eyes. Before the test, patients sit in a dark room for 30 minutes with their eyes patched. A small electrode (silver disk) is taped to their forehead. The eye patches are then removed, the eyes are numbed with drops, and contact lenses are placed in the eyes. The contact lenses sense small electrical s
Conditions Studied
Study Locations (2)
Colorado
- Rocky Mountain Lions Eye Institute - Denver
Maryland
- National Institutes of Health Clinical Center, 9000 Rockville Pike - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 350 participants |
| Start Date | 2004-01-14 |
| Est. Completion | 2008-10-28 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00076271
The ClinicalTrials.gov registry entry for NCT00076271 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 350 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 741,290-participant average among 27 other Eye Diseases trials with a reported enrollment target (100% lower). The listed sponsor is National Eye Institute (NEI), which has 221 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Eye Diseases appearing as the primary indexed condition, and to 0 interventions.
NCT00076271 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Colorado, Maryland.
Frequently Asked Questions
What is clinical trial NCT00076271 about?
NCT00076271 is a clinical study titled "Evaluation and Treatment of Pediatric, Developmental, and Genetic Eye Diseases". This study will evaluate and treat children or adults with inherited or developmental eye conditions. It will allow specialists in pediatric ophthalmology, genetic ophthalmology, and ocular motility at the National Eye Institute (NEI) to learn more about the course of various pediatric, genetic, dev...
What is the current status of trial NCT00076271?
This trial is currently completed. The enrollment target is 350 participants. The study started on 2004-01-14. Estimated completion is 2008-10-28.
What conditions does trial NCT00076271 study?
This clinical trial studies the following conditions: Eye Diseases.
Who is sponsoring clinical trial NCT00076271?
This trial is sponsored by National Eye Institute (NEI), which has 221 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00076271 being conducted?
This trial has 2 study locations across Colorado, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Eye Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Adaptive Optics Retinal Imaging
RECRUITING
-
Study to Evaluate Sepofarsen in Subjects With Leber Congenital Amaurosis (LCA) Type 10 (HYPERION)
RECRUITING · Phase 3
-
Widefield Confocal Scanning Laser Ophthalmoscope Optimized for Pediatric and Neonatal Imaging
RECRUITING
-
SGLT2 Inhibitors in Geographic Atrophy
RECRUITING · Phase 2
-
Michigan Screening and Intervention for Glaucoma and Eye Health Through Telemedicine (SIGHT) 2
RECRUITING · NA
-
IRIS Registry: Intelligent Research in Sight Registry
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.